• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Shanda Interactive Entertainment

Shanda Interactive Entertainment

  1. All
  2. 3rd Party
  3. Investing
  1. Synergy Pharmaceuticals Announces Acceptance of Supplemental New Drug Application (sNDA ) for TRULANCE™ (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation ...

    Synergy Pharmaceuticals Announces Acceptance of Supplemental New Drug Application ( sNDA ) for TRULANCE™ (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

  2. Clovis Oncology’s Rucaparib Significantly Improved Progression-Free Survival in All Ovarian Cancer Patient Populations Studied in Phase 3 ARIEL3 Maintenance Treatment Trial

    Clovis Oncology’s Rucaparib Significantly Improved Progression-Free Survival in All Ovarian Cancer Patient Populations Studied in Phase 3 ARIEL3 Maintenance Treatment Trial

  3. Ways to Play China's Online Gaming Sector

    Think big if you're serious about investing in virtual fun and games.

©2017 Morningstar Advisor. All right reserved.